Most Recent Headlines

• PSM: May 26th, 2022, 11:25Length: 1680
  Pfizer Inc (PFE) Breaks Through Resistance at $54.16
• BIZ: May 26th, 2022, 06:45Length: 9545
  Pfizer Granted FDA Fast Track Designation for Ervogastat/Clesacostat Combination for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
• BIZ: May 25th, 2022, 10:00Length: 4691
  Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
• BIZ: May 25th, 2022, 03:00Length: 10378
  Pfizer Launches 'An Accord for a Healthier World' to Improve Health Equity for 1.2 Billion People Living in 45 Lower-Income Countries
• BIZ: May 24th, 2022, 06:45Length: 14155
  Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod's Potentially Best-in-Class Profile in Ulcerative Colitis
• BIZ: May 23rd, 2022, 06:45Length: 29801
  Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose
• SRD: May 23rd, 2022, 06:37Length: 4877
  Pfizer PFE Proactive Strategies
• ANH: May 22nd, 2022, 10:51Length: 10148
  Amphetamine Drug Market Development Opportunities, Future Plans, Competitive Landscape and Growth by Forecast 2028
• SME: May 20th, 2022, 12:30Length: 9813
  3 Health Care Stocks To Watch Right Now
• ANH: May 18th, 2022, 11:20Length: 9573
  Norepinephrine Drug Market Size & Top Key Players;Pfizer Inc. (NYSE: PFE), Sanofi (EPA: SAN), Mylan N.V. (NASDAQ: MYL), Cardinal Health (NYSE: CAH)